Cargando…
Intra-tumor heterogeneity in head and neck cancer and its clinical implications
The presence of heritable differences among cancer cells within a tumor, called intra-tumor genetic heterogeneity, has long been suspected of playing a role in poor responses to therapy. Research over the past decade has documented the existence of such heterogeneity within tumors of individual pati...
Autores principales: | Mroz, Edmund A., Rocco, James W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
KeAi Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477669/ https://www.ncbi.nlm.nih.gov/pubmed/28642939 http://dx.doi.org/10.1016/j.wjorl.2016.05.007 |
Ejemplares similares
-
Novel p53 therapies for head and neck cancer
por: Castellanos, Mario R., et al.
Publicado: (2016) -
The current status of oncolytic viral therapy for head and neck cancer
por: Old, Matthew O., et al.
Publicado: (2016) -
Interleukin-6 role in head and neck squamous cell carcinoma progression
por: Choudhary, Moaz M., et al.
Publicado: (2016) -
mTOR, metabolism, and the immune response in HPV-positive head and neck squamous cell cancer
por: Coppock, Joseph D., et al.
Publicado: (2016) -
Intra-tumor Genetic Heterogeneity and Mortality in Head and Neck Cancer: Analysis of Data from The Cancer Genome Atlas
por: Mroz, Edmund A., et al.
Publicado: (2015)